 | |
| Company type | Public |
|---|---|
| BSE: 533573 NSE: APLLTD | |
| Industry | Pharmaceuticals |
| Founded | 1907[1] |
| Headquarters | , India |
Area served | Worldwide |
Key people | Chirayu Amin (Chairman) Pranav Amin (MD) Shaunak Amin (MD) |
| Products | Pharmaceuticals, Branded and Generic drugs, |
| Revenue |  ₹ 31.31 billion (US$ 470.632 million) (2016-2017)[3] |
| ₹ 4.01 billion (US$ 60.276 million) (2016-2017)[3] | |
Number of employees | 9000+ (2017)[3] |
| Parent | Alembic Group |
| Website | www |
Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara.[2] It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.[2]
The company has its headquarters and corporate office situated in Vadodara, Gujarat, India, while its manufacturing facilities are located at Panelav, Karakhadi in Gujarat and Sikkim, India.[2][4] Its Panelav plant houses active pharmaceutical ingredients (APIs) and formulation manufacturing, while its Sikkim plant is involved in manufacture of formulations for Indian and non-regulated export markets.[5]
- ^ "Pricing pressure: Alembic may exit penicillin-G business". Times of India. 27 February 2004. Retrieved 9 January 2017.
- ^ a b c d "Alembic Pharmaceuticals Ltd". profit.ndtv.com. Retrieved 26 December 2016.
- ^ a b c "Annual Report 2016-17" (PDF). Archived from the original (PDF) on 17 November 2017. Retrieved 24 November 2017.
- ^ "Alembic Pharmaceuticals". CNBC moneycontrol. Retrieved 3 January 2017.
- ^ "Alembic Pharmaceuticals receives FDA approval for hypertension tablets". RTN.Asia. 18 November 2016. Retrieved 3 January 2017.